Clinical trials
Type 1 diabetes clinical trials
An autoimmune condition where the body makes little or no insulin. We’re tracking 862 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07142681Recruiting
How adults' diets change when caring for a child with new type 1 diabetes
This study looks at how the eating habits of adults change when they care for a child newly diagnosed with type 1 diabetes. The goal is to understand what you go through and find better ways to support families.
BarcelonaAges 18 years+ - NCT07126873RecruitingPhase 1/Phase 2
Study of E-islet 01 for type 1 diabetes with severe low blood sugar
This study tests a new treatment called E-islet 01, which may help people with type 1 diabetes who have very low natural insulin production and have had dangerous low blood sugar events. The goal is to see if it is safe and can reduce those episodes.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07122180Enrolling by invitation
14-day study of a new continuous glucose monitor for diabetes
This study tests a new continuous glucose monitor (CGM) that you wear for 14 days. It checks how accurate the device is and how well it helps track your blood sugar levels, all while being safe and easy to use.
Riga, RigaAges 18–80 - NCT07118098Recruiting
Early detection of type 1 diabetes in families and friends
This study is for people ages 1 to 45 who have a close family member or friend with type 1 diabetes. It aims to detect type 1 diabetes early by screening people who may be at higher risk.
ViennaAges 1–45 - NCT07116434Recruiting
Discovery diabetes support for teens and young adults
This study uses a smartphone app and digital stories to help teens and young adults with type 1 diabetes learn more about managing their condition and connect with others. You may join if you have had type 1 diabetes for at least a year, have a smartphone, and have an upcoming clinic visit at Vanderbilt.
Nashville, TennesseeAges 13–21 - NCT06966427Recruiting
Using a dosing app for insulin management
This trial studies a smartphone system that helps people with diabetes decide how much insulin to take. It is for people who use insulin injections or are starting basal insulin, and it uses a continuous glucose monitor to guide dosing.
Petah TikvaAges 6–75 - NCT07107789Enrolling by invitation
Can animated videos help kids with type 1 diabetes?
This study tests whether watching short education videos with animations can help children with type 1 diabetes better manage their blood sugar, take care of themselves, and feel more positive about their condition. It's for kids aged 11 to 18 who use an insulin pen.
Erzurum, PalandökenAges 11–18 - NCT07097818Recruiting
GLITTER Study: Better Blood Sugar Control in Type 1 Diabetes
This study tests a program to help people with type 1 diabetes improve their blood sugar control using continuous glucose monitors, insulin pumps, and education sessions. It includes remote monitoring and camp activities for some participants.
Beijing, Beijing MunicipalityAges 6 years+ - NCT07097805Recruiting
GLITTER: Improving blood sugar with team, tech, and support
This study tests whether a team approach—including technology, education, and support from peers—can help people with type 1 diabetes improve their blood sugar levels. It may be a good fit if you have type 1 diabetes and are looking for extra help managing it.
Beijing, Beijing MunicipalityAges Any age - NCT07086443RecruitingPhase 4
Testing a new wound therapy for diabetic foot ulcers
This study tests a new wound therapy for diabetic foot ulcers that haven't healed with standard care. It aims to see if the therapy helps these ulcers heal better and faster.
Monroeville, PennsylvaniaAges 18 years+ - NCT07088068RecruitingPhase 3
Teplizumab for newly diagnosed type 1 diabetes
This study tests whether teplizumab can help keep the body making insulin in people recently diagnosed with type 1 diabetes. It is for children and young adults aged 1 to 25, and compares the drug against a placebo.
Scottsdale, ArizonaAges 1–25 - NCT07086989Recruiting
Heart health study for kids with chronic conditions
This study looks at heart disease risk in children and young adults (ages 6-25) with long-term health conditions like certain heart, kidney, or diabetes disorders. The goal is to better understand and manage heart risks early.
BudapestAges 6–25 - NCT07091318RecruitingEarly Phase 1
CBT for insomnia in type 1 diabetes
This study tests whether cognitive behavioral therapy for insomnia (CBTi) can improve sleep in people with type 1 diabetes. It may help those who have poor sleep quality and use a continuous glucose monitor.
Chicago, IllinoisAges 18–65 - NCT07083882RecruitingPhase 2
Capsule transplant for newly diagnosed type 1 diabetes
This study tests if taking capsules with processed donor stool can help preserve insulin-making cells in people recently diagnosed with type 1 diabetes. The treatment aims to slow the loss of insulin production.
AmsterdamAges 18–45 - NCT05585983RecruitingPhase 4
Flu shot in newly diagnosed type 1 diabetes patients
This trial checks whether giving a flu vaccine to people who were just diagnosed with type 1 diabetes affects their health and immune response. It may help doctors understand if flu vaccination is safe and useful soon after diagnosis.
AalborgAges 7–17 - NCT06984133Recruiting
Learning about diabetes for teens with type 1 diabetes
This study tests a structured education program to help Arab adolescents aged 11 to 14 better manage their blood sugar. If you have type 1 diabetes, use a continuous glucose monitor, and have not attended a diabetes education class in the last 6 months, this program may be for you.
Kuwait City, SharqAges 11–14 - NCT07062887Recruiting
Digital mindfulness for young adults with type 1 diabetes
This study tests a digital mindfulness program designed to help young adults manage the stress of living with type 1 diabetes. If you are between 18 and 30, use a continuous glucose monitor, and have a smartphone, you may be able to join.
New Haven, ConnecticutAges 18–30 - NCT07059806Recruiting
T1CARE: Help for young adults with type 1 diabetes
This trial tests a new program to help young adults with type 1 diabetes manage social factors that affect their health, like housing or food access. It aims to improve diabetes care by addressing these everyday challenges.
New Haven, ConnecticutAges 18–40 - NCT06989190Recruiting
Study of blood vessel damage in type 1 diabetes
This study looks at how type 1 diabetes affects small blood vessels, especially in the eyes, kidneys, and feet. It tests a special camera and other devices to see how severe the damage is, which may help doctors find better ways to treat complications early.
StockholmAges 18–60 - NCT07051564Recruiting
Cell injection study for type 1 diabetes
This trial tests a new cell injection (CNK-UT009) for adults with type 1 diabetes. The goal is to see if it can help manage blood sugar and reduce insulin needs.
Zibo, ShandongAges 18–65 - NCT07051005Recruiting
Online self-compassion study for diabetes distress
This trial tests a tailored online program to help people with diabetes manage distress through self-compassion skills. It's designed for those whose diabetes team feels they could use extra mental health support.
Bangor, WalesAges 18–99 - NCT07050888Recruiting
Inulin supplement study for type 1 diabetes
This study tests if taking inulin, a type of fiber, can help improve blood sugar control and immune health in people with type 1 diabetes. Participants will take a daily supplement for a period of time to see if it makes a difference.
AmsterdamAges 18–70 - NCT07038473Recruiting
Early detection of type 1 diabetes in relatives
This study screens brothers, sisters, and children of people with type 1 diabetes to find early signs of the disease before symptoms appear. The goal is to catch it early and offer monitoring or future prevention options.
Kuwait City, Al Asimah / Capital GovernorateAges 1.5 years–18 years - NCT07041268RecruitingPhase 2
Rituximab for recent type 1 diabetes in teens
This trial tests if repeated infusions of rituximab (a drug that calms the immune system) can help preserve insulin production in adolescents newly diagnosed with type 1 diabetes. It is for teens in Russia who started diabetes treatment within the last 4 months.
MoscowAges 12–18
Hear when a new Type 1 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for type 1 diabetes?
- Yes. Clin2 currently lists 862 recruiting type 1 diabetes studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a type 1 diabetes trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a type 1 diabetes trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.